Involvement of lipid peroxidation in platelet signalling

Prostaglandins Leukotrienes and Essential Fatty Acids

Volumn 57, Issue 4-5, 1997, Pages 489-491

  Lagarde, M ^a   Lemaitre, D ^a   Calzada, C ^a   Vericel E ^a  

^a UNIVERSITÉ DE LYON   (France)

Author keywords

[No Author keywords available]

Indexed keywords

GLUTATHIONE PEROXIDASE; LIPID HYDROPEROXIDE; MEMBRANE PHOSPHOLIPID; OMEGA 3 FATTY ACID; PROSTAGLANDIN DERIVATIVE; PROSTAGLANDIN ENDOPEROXIDE; THROMBOXANE A2;

ARACHIDONIC ACID METABOLISM; CONFERENCE PAPER; HUMAN; LIPID PEROXIDATION; NONHUMAN; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; THROMBOCYTE ACTIVATION;

EID: 0030735946     PISSN: 09523278     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0952-3278(97)90433-6     Document Type: Conference Paper

References (26)

1. Lagarde M. Metabolism of fatty acids by platelets and the functions of various metabolites in mediating platelet function. Progr Lipid Res 1988; 27: 135-152.
2. Lands W. E. M., Kulmacz R. J. The regulation of the biosynthesis of prostaglandins and leukotrienes. Progr Lipid Res 1986; 25: 105-109.
3. Smith W. L., Eling T. E., Kulmacz R. J., Marnett L. J., Tsai A. Tyrosyl radicals and their role in hydroperoxide-dependent activation and inactivation of prostaglandin endoperoxide synthase. Biochemistry 1992; 31: 3-7.
4. Kulmacz R. J., Lands W. E. M. Requirements for hydroperoxide by the cyclooxygenase and peroxidase activities of prostaglandin H synthase. Prostaglandins 1983; 25: 531-540.
5. Siegel M. I., Mc Connell R. T., Abrahams S. L., Porter N. A., Cuatrecasas P. Regulation of arachidonate metabolism via lipoxygenase and cyclooxygenase by 12-HPETE, the product of human platelet lipoxygenase. Biochem Biophys Res Commun 1979; 89: 1273-1280.
6. Croset M., Lagarde M. Enhancement of eicosaenoic acid lipoxygenation in human platelets by 12-hydroperoxy derivative of arachidonic acid. Lipids 1985; 20: 743-750.
7. Leaf A., Weber P. C. Cardiovascular effects of n-3 fatty acids. New Engl J Med 1988; 318: 549-557.
8. Croset M., Guichardant M., Lagarde M. Different metabolic behavior of long chain n-3 polyunsaturated fatty acid in human platelets. Biochim Biophys Acta 1988; 961: 262-269.
9. 2 receptor binding and function. J Biol Chem 1990; 265: 21692-21697.
10. 2 receptor by eicosapentaenoic and docosahexaenoic acids in intact and solubilized platelet membranes. J Biol Chem 1992; 67: 6541-6547.
11. 2 receptor agonists. Biochem Pharmacol 1993; 46: 245-249.
12. Brown J. E., Wahle K. W. J. Effect of fish oil and vitamin E supplementation on lipid peroxidation and whole-blood aggregation in man. Clin Chim Acta 1990; 193: 147-156.
13. Harats D., Dabach Y., Hollander G., et al. Fish oil ingestion in smokers and nonsmokers enhance peroxidation of plasma lipoproteins. Atherosclerosis 1991; 90: 127-139.
14. Hammarström S., Falardeau P. Resolution of prostaglandin endoperoxide synthase and thromboxane synthase of human platelets. Proc Natl Acad Sci USA 1977; 74: 3691-3695.
15. Véricel E., Rey C., Calzada C., Haond P., Chapuy P. H., Lagarde M. Age-related changes in arachidonic acid peroxidation and glutathione-peroxidase activity in human platelets. Prostaglandins 1992; 43: 75-85.
16. Muruganandam A., Drouillard C., Thibert R. J., Cheung R. M. C., Draisey T. F., Mutus B. Glutathione metabolic enzyme activities in diabetic platelets as a function of glycemic control. Thromb Res 1992; 67: 385-397.
17. Hasselmark L., Malmgren R., Unze G., Zetterstrom O. Lowered platelet glutathione peroxidase activity in patients with intrinsic asthma. Allergy 1990; 45: 523-527.
18. Rey C., Véricel E., Némoz G., Chen W., Chapuy P., Lagarde M. Purification and characterization of glutathione peroxidase from human blood platelets. Age-related changes in the enzyme. Biochim Biophys Acta 1994; 1226: 219-224.
19. Véricel E., Croset M., Sedivy P., Courpron P. H., Dechavanne M., Lagarde M. Platelets and aging. I-Aggregation, arachidonate metabolism and antioxidant status. Thromb Res 1988; 49: 331-342.
20. Calzada C., Véricel E., Lagarde M. Decrease in platelet reduced glutathione increases lipoxygenase activity and decreases vitamin E. Lipids 1991; 26: 696-699.
21. Calzado C., Véricel E., Lagarde M. Low concentrations of lipid hydroperoxides, prime human platelet aggregation specifically via cyclo-oxygenase activation. Biochem J 1997; 325: 495-500.
22. Driss F., Véricel E., Lagarde M., Dechavanne M., Darcet P. Inhibition of platelet aggregation and thromboxane synthesis after intake of small amount of icosapentaenoic acid. Thromb Res 1984; 36: 389-396.
23. Croset M., Véricel E., Rigaud M., et al. Functions and tocopherol content of blood platelets from elderly people after low intake of purified eicoapentaenoic acid. Thromb Res 1990; 57: 1-12.
24. Calzada C., Véricel E., Lagarde M. Lower of lipid peroxidation in human platelets incubated with eicosapentaenoic acid. Biochim Biophys Acta 1992; 1127: 147-152.
25. Joulain C., Prigent A. F., Némoz G., Lagarde M. Increased glutathione peroxidase activity in human blood mononuclear cells upon in vitro incubation with n-3 fatty acids. Biochem Pharmacol 1994; 47: 1315-1323.
26. Polette A., Lemaitre D., Lagarde M., Véricel E. N-3 fatty acid-induced lipid peroxidation in human platelets is prevented by catechins. Thromb Haemostas 1996; 75: 945-949.